Li M, Li Y, Wang L, Xu F, Guo X, Zhang J
Front Chem. 2023; 11:1179956.
PMID: 37408563
PMC: 10318440.
DOI: 10.3389/fchem.2023.1179956.
Nasuhipur F, Ghasemi Z, Poupon M, Dusek M
RSC Adv. 2023; 13(26):17812-17816.
PMID: 37323449
PMC: 10261912.
DOI: 10.1039/d3ra02515b.
Wojciechowski M, Schreiber S, Jose J
Pharmaceuticals (Basel). 2023; 16(5).
PMID: 37242492
PMC: 10224427.
DOI: 10.3390/ph16050710.
Diaz-de-Cerio E, Giron F, Perez-Garrido A, Pereira A, Gabaldon-Hernandez J, Verardo V
Int J Mol Sci. 2023; 24(6).
PMID: 36982836
PMC: 10057723.
DOI: 10.3390/ijms24065761.
Liu F, Sun T, Yang Y, Huang C, Chen X
RSC Adv. 2022; 8(23):12635-12640.
PMID: 35541228
PMC: 9079339.
DOI: 10.1039/c8ra01236a.
4,5,7-Trisubstituted indeno[1,2-b]indole inhibits CK2 activity in tumor cells equivalent to CX-4945 and shows strong anti-migratory effects.
Birus R, El-Awaad E, Ballentin L, Alchab F, Aichele D, Ettouati L
FEBS Open Bio. 2021; 12(2):394-411.
PMID: 34873879
PMC: 8804612.
DOI: 10.1002/2211-5463.13346.
4,5,6,7-Tetrahydroindol-4-Ones as a Valuable Starting Point for the Synthesis of Polyheterocyclic Structures.
Horsten T, Dehaen W
Molecules. 2021; 26(15).
PMID: 34361747
PMC: 8348459.
DOI: 10.3390/molecules26154596.
Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-]indole Derivative, Discovered as CK2 Inhibitor.
El-Awaad E, Birus R, Marminon C, Bouaziz Z, Ballentin L, Aichele D
Pharmaceuticals (Basel). 2021; 14(6).
PMID: 34198928
PMC: 8226678.
DOI: 10.3390/ph14060542.
Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles.
Henrique Kita D, Guragossian N, Fatima Zattoni I, Rotuno Moure V, Gomes de Moraes Rego F, Lusvarghi S
Sci Rep. 2021; 11(1):1788.
PMID: 33469044
PMC: 7815716.
DOI: 10.1038/s41598-020-79892-w.
QSAR Model of Indeno[1,2-]indole Derivatives and Identification of -isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-]furan-3-carboxamide as a Potent CK2 Inhibitor.
Haidar S, Marminon C, Aichele D, Nacereddine A, Zeinyeh W, Bouzina A
Molecules. 2020; 25(1).
PMID: 31888043
PMC: 6982966.
DOI: 10.3390/molecules25010097.
Diacritic Binding of an Indenoindole Inhibitor by CK2α Paralogs Explored by a Reliable Path to Atomic Resolution CK2α' Structures.
Lindenblatt D, Nickelsen A, Applegate V, Hochscherf J, Witulski B, Bouaziz Z
ACS Omega. 2019; 4(3):5471-5478.
PMID: 31559376
PMC: 6756786.
DOI: 10.1021/acsomega.8b03415.
Three-Component One-Pot Synthesis of Highly Functionalized Bis-Indole Derivatives.
Chen X, Xiong S, Xie Z, Wang Y, Liu W
ACS Omega. 2019; 4(7):11832-11837.
PMID: 31460292
PMC: 6682060.
DOI: 10.1021/acsomega.9b01159.
Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.
Nacereddine A, Bollacke A, Roka E, Marminon C, Bouaziz Z, Fenyvesi F
Pharmaceuticals (Basel). 2018; 11(1).
PMID: 29373552
PMC: 5874706.
DOI: 10.3390/ph11010010.
Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.
Hochscherf J, Lindenblatt D, Witulski B, Birus R, Aichele D, Marminon C
Pharmaceuticals (Basel). 2017; 10(4).
PMID: 29236079
PMC: 5748653.
DOI: 10.3390/ph10040098.
Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: effect of the regulatory subunit.
Baier A, Nazaruk J, Galicka A, Szyszka R
Mol Cell Biochem. 2017; 444(1-2):35-42.
PMID: 29188536
PMC: 6002439.
DOI: 10.1007/s11010-017-3228-1.
Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining.
Haidar S, Bouaziz Z, Marminon C, Laitinen T, Poso A, Le Borgne M
Pharmaceuticals (Basel). 2017; 10(1).
PMID: 28075359
PMC: 5374412.
DOI: 10.3390/ph10010008.
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.
Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Honorat M, Guragossian N
Drug Des Devel Ther. 2015; 9:3481-95.
PMID: 26170632
PMC: 4498724.
DOI: 10.2147/DDDT.S84982.
Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2.
Alchab F, Ettouati L, Bouaziz Z, Bollacke A, Delcros J, Gertzen C
Pharmaceuticals (Basel). 2015; 8(2):279-302.
PMID: 26061121
PMC: 4491662.
DOI: 10.3390/ph8020279.